CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for AbCellera Biologics Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

AbCellera Biologics Inc
2215 Yukon Street
Phone: (604) 559-9005p:604 559-9005 Vancouver, BC  V5Y 0A1  Canada Ticker: ABCLABCL

Business Summary
AbCellera Biologics Inc. is focused on the development of antibody-based drugs and is committed to improving discovery and development. It is engaged in antibody discovery and development engine is specifically designed to break the barriers of conventional discovery. It provides biotech and pharmaceutical companies with an advantage that empowers them to move quickly, reduce cost, and tackle the toughest problems in drug development. The Company uses the engine to both work with partners to build a large and diversified portfolio of royalty stakes in antibody drugs and to develop its own pipeline of antibody drugs. The Company partners with companies of all sizes, from biotechnology companies to pharmaceutical companies-propelling programs to the clinic, together. It generates a range of diverse antibodies with immunization strategies and single-cell screening.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202312/31/2023YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, President, Chief Executive Officer, Co-Founder Carl L.Hansen 48 11/1/2012 11/1/2012
Co-Founder, Chief Operating Officer, Director VeroniqueLecault 38 1/1/2019 8/1/2018
Chief Financial Officer AndrewBooth 49 8/1/2019 6/1/2016
6 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Trianni, Inc. 1515 5th Avenue San Francisco CA United States

Business Names
Business Name
AbCellera Properties Inc.
AbCellera Quebec Inc. Canada Lineage Biosciences Inc. Delaware Trianni Inc.
ABCL
4 additional Business Names available in full report.

General Information
Number of Employees: 586 (As of 12/31/2023)
Outstanding Shares: 292,782,152 (As of 2/15/2024)
Shareholders: 75
Stock Exchange: NASD


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, March 29, 2024